Inhibition of fusidic acid resistance through restricting conformational flexibility in domain III of EF-G.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41284881.
- Also identified by DOI 10.1073/pnas.2508779122 and PMC identifier 12685103.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Fusidic acid (FA) is one of few remaining antibiotics active against Methicillin-resistant <i>Staphylococcus aureus</i>. FusB confers resistance to FA by rescuing the translocation factor Elongation Factor-G (EF-G) from FA-stalled ribosome complexes. FusB induces allosteric effects on dynamics in EF-G, causing significant changes in the conformational flexibility of domain III that result in an increase in a minor, more disordered state, overcoming the steric block induced by FA. We show that restraining flexibility in the two central β-strands of EF-G domain III prevents the FusB-induced increase in this minor state population, preventing FusB-mediated release of EF-G from the ribosome and thereby reinstating FA-induced stalling of protein synthesis. We further identify a region controlling access to the minor state population, potentially pinpointing the allosteric mechanism within domain III by which FusB acts. Our findings suggest a possible region that could be targeted for rational design of an inhibitor of FusB-mediated conformational flexibility, reinstating FA sensitivity even in the presence of FusB, which could rejuvenate the efficacy of this clinically important antibiotic.
Medical subject headings
- Fusidic Acid
- Peptide Elongation Factor G
- Anti-Bacterial Agents
- Drug Resistance, Bacterial
- Bacterial Proteins